Author:
Gray Jerilyn K.,Paluch Andrew M.,Stuart William D.,Waltz Susan E.
Reference27 articles.
1. Cancer statistics, 2010;Jemal;CA Cancer J. Clin.,2010
2. Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor;de Bono;Clin. Cancer Res.,2007
3. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models;Agus;Cancer Res.,1999
4. Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures;Vicentini;J. Cancer Res. Clin. Oncol.,2003
5. Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer;Sirotnak;Clin. Cancer Res.,2002
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献